Approval · Notice of Compliance 4407 · 1996
MEGALONE: Notice of Compliance 4407
Issued August 21, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4407
- Date
- August 21, 1996
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antibacterial
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MEGALONE | 02227398 | — |
| MEGALONE | 02227401 | — |
| MEGALONE | 02227371 | — |
Medicinal ingredients
- FLEROXACIN 200 MG per TAB
- FLEROXACIN 400 MG per TAB
- FLEROXACIN 4 MG per ML